关键数据
8.650今开
9.400最高
23.21K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.07%换手率
8.600昨收
8.650最低
212.30K成交额
亏损市盈率静
10.76市净率
0.00%股息率 TTM
-47.08%ROA
19.63052周最高
0.03量比
-18.91M净利润
32.05M总股本
-1.0079每股收益TTM
1.30Beta
-149.72%ROE
8.27052周最低
13.02%振幅
58.46%毛利率
293.90M总市值
0.41回报/风险
5.39%风险率

即将为您带来更多新闻,敬请期待。。。
Clearpoint Neuro Inc评分
0.06与上次评分对比预测9.00
财务诊断6.38
技术分析5.49
公司估值7.86
机构认同度5.00
风险评估3.70
分析师评级
强力买入评级
21.500目标均价
+101.50%涨幅空间
Clearpoint Neuro Inc 最新财报电话会记录
ClearPoint Neuro (CLPT) 2026年第三季度业绩电话会议: 营收增长36%, 2027年催化剂可期
ClearPoint Neuro 2026年第三季度财报电话会议:营收增长36%至1210万美元,现金余额达4620万美元,管理层概述了2027年的重大催化因素。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Clearpoint Neuro Inc 简介
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
行业医疗设备与耗材
公司代码CLPT
员工数量115
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| BlackRock Institutional Trust Company, N.A. | 6.04% |
|---|
| MAK Capital One, LLC | 5.77% |
|---|
| Bigger Capital Funds, LP | 4.54% |
|---|
| Vanguard Capital Management, LLC | 4.15% |
|---|
| 股东类型 | 占比 |
|---|
| Investment Advisor | 24.64% |
|---|
| Hedge Fund | 15.56% |
|---|
| Investment Advisor/Hedge Fund | 9.43% |
|---|
| Individual Investor | 5.49% |
|---|
常见问题
Clearpoint Neuro Inc(CLPT)的当前股价是多少?
Clearpoint Neuro Inc(CLPT)的当前股价是 9.17。
Clearpoint Neuro Inc的股票代码是什么?
Clearpoint Neuro Inc的股票代码是CLPT。
Clearpoint Neuro Inc股票的52周最高点是多少?
Clearpoint Neuro Inc股票的52周最高点是19.63。
Clearpoint Neuro Inc股票的52周最低点是多少?
Clearpoint Neuro Inc股票的52周最低点是8.27。
Clearpoint Neuro Inc的市值是多少?
Clearpoint Neuro Inc的市值是293.90M。
现在Clearpoint Neuro Inc(CLPT)的股票是买入、持有还是卖出?
根据分析师评级,Clearpoint Neuro Inc(CLPT)的总体评级为STRONG BUY,目标价格为21.50。
Clearpoint Neuro Inc(CLPT)股票的每股收益(EPS TTM)是多少
Clearpoint Neuro Inc(CLPT)股票的每股收益(EPS TTM)是-1.01。